Position in LLY
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$5,542,566
+$1,393,484 QoQ
Shares Held
4,621
+2.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#1,637
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DEARBORN PARTNERS LLC holds $75,110,921 across 10 Drug Manufacturers - General names. LLY ranks #4 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
114,591 | $28,835,679 | |
| 2 | JNJ |
Johnson & Johnson
|
79,895 | $20,290,932 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
67,003 | $8,465,159 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
4,621 | $5,542,566 | |
| 5 | NVS |
Novartis AG
|
32,039 | $5,021,152 | |
| 6 | MRK |
Merck & Co., Inc.
|
28,921 | $3,716,348 | |
| 7 | GSK |
GSK plc
|
23,142 | $1,213,103 | |
| 8 | PFE |
Pfizer Inc
|
40,635 | $978,490 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,542,566 | 4,621 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $4,149,082 | 4,511 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,625,423 | 4,304 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,575,418 | 4,686 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,797,870 | 4,872 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,230,311 | 5,122 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $3,815,224 | 4,942 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $4,166,575 | 4,703 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $4,208,206 | 4,648 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $3,587,173 | 4,611 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,726,316 | 4,677 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $2,441,792 | 4,546 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $2,194,826 | 4,680 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,591,751 | 4,635 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,675,547 | 4,580 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,522,331 | 4,708 | Shares | Sole | 2022-11-21 | |
| 2022-06-30 | $1,484,973 | 4,580 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $1,282,937 | 4,480 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,241,332 | 4,494 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $1,038,338 | 4,494 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $1,030,085 | 4,488 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $838,448 | 4,488 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $734,960 | 4,353 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $566,620 | 3,828 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $685,779 | 4,177 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $576,104 | 4,153 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||